|
Sabra Health Care Reit Inc (NASDAQ: SBRA) |
|
|
|
| |
Sabra Health Care Reit Inc Outlook |
On November 1 2024 the Sabra Health Care Reit Inc provided following guidance
nnSabra Health Care REIT, Inc. Announces Third Quarter 2024 Results and Provides Update on Financial Guidance for 2024nn
nnTUSTIN, Calif.nn — Sabra Health Care REIT, Inc. (Nasdaq: SBRA) has released its financial results for the third quarter of 2024, highlighting the company’s performance and key operational metrics. While the announcement included a notable update on the financial guidance for the upcoming year, specific figures were not disclosed in the text.
In terms of performance for the third quarter of 2024, the company reported the following results per diluted common share:
- nnNet Income:nn $0.13
- nnFunds From Operations (FFO):nn $0.34
- nnNormalized FFO:nn $0.35
- nnAdjusted Funds From Operations (AFFO):nn $0.36
- nnNormalized AFFO:nn $0.37
The report also provided insights into the company’s EBITDARM (Earnings Before Interest, Taxes, Depreciation, Amortization, Rent, and Management Fees) coverage ratios, which are crucial for assessing the operational efficiency of its healthcare facilities. The coverage ratios for the different segments were as follows:
- nnSkilled Nursing/Transitional Care:nn 1.94x
- nnSenior Housing - Leased:nn 1.37x
These figures suggest a solid operational performance, particularly within the skilled nursing and transitional care sectors, indicating the company’s ability to cover its expenses and obligations related to its healthcare real estate investments.
Regarding guidance for 2024, Sabra Health Care REIT indicated there would be updates, though the specifics of these projections were not elaborated in the current report. This lack of detailed forecasts may prompt stakeholders to seek further clarity in upcoming communications or earnings calls to comprehend the company’s strategic direction and potential financial outlook for the year ahead.
Investors and s will be keen to monitor how Sabra’s operations evolve in response to market conditions and legislative changes affecting the healthcare real estate sector as the company navigates the remainder of 2024.,
|
On August 8 2024 the Sabra Health Care Reit Inc provided following guidance
nnSabra Health Care REIT, Inc. Reports Strong Second Quarter 2024 Performance; Raises Full-Year Guidancenn
TUSTIN, Calif. – August 8, 2024 – Sabra Health Care REIT, Inc. (Sabra, the Company, or we) (Nasdaq: SBRA) has today released its operational results for the second quarter of 2024, showcasing a solid performance across key financial metrics. In addition, the company has updated its full-year guidance for 2024, indicating a positive outlook for the remainder of the year.
nnFinancial Highlights for Q2 2024nn
For the second quarter of 2024, Sabra reported the following results per diluted common share:
- nnNet Income:nn $0.10
- nnFunds From Operations (FFO):nn $0.35
- nnNormalized FFO:nn $0.35
- nnAdjusted Funds From Operations (AFFO):nn $0.36
- nnNormalized AFFO:nn $0.36
These metrics reflect the company's continued commitment to maintaining robust financial health while effectively managing its portfolio of health care properties.
nnEBITDARM Coverage Overviewnn
The company's earnings before interest, taxes, depreciation, amortization, rent, and management fees (EBITDARM) coverage ratios, which provide insight into the operational performance of its properties, are as follows:
- nnSkilled Nursing/Transitional Care:nn 1.85x
- nnSenior Housing - Leased:nn 1.35x
These coverage ratios indicate a strong performance within Sabra's operational segments, demonstrating the ability of its underlying assets to generate sufficient earnings to support ongoing obligations.
nnIncreased Guidance for 2024nn
In light of these positive results, Sabra has raised its guidance for the full year of 2024, signaling confidence in the company’s performance trajectory. While specific figures for the updated guidance have not yet been disclosed, the decision to increase expectations reflects a strong operational foundation and positive market conditions.
Overall, Sabra's strong earnings, coupled with improved EBITDARM coverage ratios and an upward revision of its annual guidance, highlight the company’s strategic growth and resilience in the healthcare REIT sector. The management team remains optimistic about the future, focusing on maximizing shareholder value and sustaining growth in the evolving health care landscape.
For further updates and detailed financial information, please stay tuned for future earnings releases and company announcements.,
|
On August 7 2024 the Sabra Health Care Reit Inc provided following guidance
nnSabra Health Care REIT, Inc. Adjusts 2024 Projections Amid Positive Q2 Outcomesnn
On August 7, 2024, Sabra Health Care REIT, Inc. (Nasdaq: SBRA) unveiled its financial performance for the second quarter of 2024, revealing an overall optimistic trajectory for the company. While specific numerical details regarding the updated financial guidance for 2024 were not disclosed, the management has confirmed an increase in projections, indicating a more favorable outlook for the remaining fiscal year.
nnFinancial Performance Highlights for Q2 2024nn
In Tustin, California, Sabra reported important metrics for the second quarter, offering a glimpse into its operational efficiency. For the quarter ending June 30, 2024, the performance per diluted common share is summarized as follows:
- nnNet Income:nn $0.10
- nnFunds from Operations (FFO):nn $0.35
- nnNormalized FFO:nn $0.35
- nnAdjusted Funds from Operations (AFFO):nn $0.36
- nnNormalized AFFO:nn $0.36
These figures underscore a robust financial footing as Sabra continues to navigate the evolving healthcare real estate landscape.
nnEBITDARM Coverage Overviewnn
The company's EBITDARM (Earnings Before Interest, Taxes, Depreciation, Amortization, Rent, and Management Fees) coverage ratio indicates its operational stability across various segments:
- nnSkilled Nursing/Transitional Care:nn 1.85x
- nnSenior Housing - Leased:nn 1.35x
These ratios reflect Sabra's ability to cover its operational expenses and commitments, reinforcing its financial health and strategic positioning.
nnLooking Aheadnn
As Sabra moves through the latter half of 2024, the raised guidance signifies confidence in its growth strategies and market conditions. Investors and stakeholders are encouraged to monitor future announcements for more detailed financial objectives and expectations as the company seeks to capitalize on opportunities in the healthcare real estate sector.
Overall, with a solid performance in Q2 and an optimistic revision for the annual outlook, Sabra Health Care REIT continues to demonstrate its commitment to delivering value and enhancing shareholder returns amid a dynamic market environment.,
|
On May 9 2024 the Sabra Health Care Reit Inc provided following guidance
For the first quarter of 2024, Sabra Health Care REIT, Inc. reported a net income of $0.11 per diluted common share, FFO of $0.32 per diluted common share, normalized FFO of $0.34 per diluted common share, AFFO of $0.35 per diluted common share, and normalized AFFO of $0.35 per diluted common share. The EBITDARM coverage summary for skilled nursing and transitional care was 1.79x, excluding the Provider Relief Fund.
The company remains focused on providing high-quality healthcare real estate assets and delivering value to its shareholders. Sabra Health Care REIT, Inc. continues to monitor market conditions and make strategic investments to drive growth and profitability.
For the full year 2024, Sabra Health Care REIT, Inc. reiterates its guidance and remains confident in its ability to achieve its financial targets. The company is committed to maintaining a strong financial position and delivering consistent returns to its investors.
Overall, Sabra Health Care REIT, Inc. is pleased with its first quarter performance and is optimistic about its prospects for the remainder of the year. The company looks forward to capitalizing on opportunities in the healthcare real estate market and continuing to create long-term value for its stakeholders.
|
|
|
|
